SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending following recent analyst downgrades, which many in the community interpret as a strategic effort by institutions to accumulate shares at lower prices. Despite ongoing discussions about profitability and past governance, there is strong community focus on the company's significant revenue growth in AI infrastructure and its recent expansion into new sectors like AI-powered retail solutions. The market awaits upcoming earnings for further clarity on its trajectory and the impact of these developments.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending after an analyst upgrade highlighted robust hyperscaler demand and projected sell-outs of its server CPUs for future periods, signaling strong momentum in its AI accelerator pipeline. This news is fueling optimistic community discussions about significant market share gains and potential for continued growth. However, a segment of the community remains cautious, citing the stock's historical volatility and intense competition within the semiconductor industry.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings (RCAT) is trending following strong preliminary Q4 2025 revenue results, generating significant community buzz around its potential for major defense contracts. Investors are highly optimistic about RCAT's Black Widow drones, speculating on their recent use in military operations and eagerly anticipating awards from the upcoming Drone Dominance Program, with many also noting high short interest and perceived undervaluation.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

AHMA is trending sharply upward on unusually high volume, sparking intense community discussion about its low float and potential for a significant short squeeze. Traders are actively drawing parallels to other recent high-flying IPOs, highlighting the price action despite a lack of explicit company news.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending after reporting financial results that surpassed expectations, kicking off the bank earnings season. The community is actively discussing the company's strong performance and CEO Jamie Dimon's resilient economic outlook, though some traders are weighing a significant credit reserve build related to the Apple Card transition and potential impacts from proposed credit card interest rate caps.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BriaCell Therapeutics is trending after reporting the sustained complete resolution of lung metastasis in a single patient with advanced breast cancer treated with its Bria-OTS personalized immunotherapy. This promising clinical update has ignited strong bullish sentiment and speculation about significant price movement, though many investors remain cautious due to the stock's history of offerings and reverse splits. The company continues to advance its Phase 3 trials, with further data expected at upcoming medical conferences, maintaining a mixed outlook among the community.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending following a softer-than-expected core CPI report, signaling inflation may be cooling faster than anticipated. This dovish surprise is fueling widespread market optimism and driving expectations for a strong rally, despite some community members expressing skepticism about the reported economic data. Discussions revolve around whether this signals continued upside or if underlying economic concerns will eventually lead to a shift.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors keenly anticipate potential breakthroughs for its GaN and SiC power solutions, which are critical for energy-efficient next-generation AI data centers and strategic alignment with key industry players like NVIDIA. The community is highly focused on the stock's significant short interest, sparking intense discussion about a potential squeeze and a substantial breakout driven by its foundational technology in the evolving AI ecosystem.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI Corp. is trending after signaling an operating inflection with substantially raised 2026 revenue guidance, bolstered by recent acquisitions and increasing contracted demand. The community is actively discussing the company's long-term potential within the booming AI and drone defense sector, anticipating significant military contracts and a possible short squeeze. This strategic update highlights the company's positioning to capitalize on the growing demand for embedded AI and autonomous solutions, despite ongoing debates over current revenue figures and market volatility.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending following its recent earnings, as a beat on quarterly expectations was overshadowed by cautious guidance for the upcoming year, leading to a share price decline. The community is actively discussing whether external factors like a government shutdown impacted the outlook, or if investor focus remains on long-term growth. Despite the market reaction, management highlights strong demand across premium and business travel, positioning Delta positively within the broader airline sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?

Based on the average brokerage recommendation (ABR), CRISPR Therapeutics (CRSP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

CRISPR Therapeutics AG (CRSP) closed at $53.84 in the latest trading session, marking a -4.54% move from the prior day.

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Hold" from Analysts

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) have earned an average recommendation of "Hold" from the twenty-two analysts that are currently covering the stock, Marketbeat.com...

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 8.7% - Still a Buy?

CRISPR Therapeutics (NASDAQ:CRSP) Trading 8.7% Higher - Time to Buy...

Three Genomics Stocks Worth Tracking This Year 

Genomics advances are reshaping drug discovery, with Pacific Biosciences of California emerging as a key player in next-gen sequencing.

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a +2.58% change from its previous close.

Interesting CRSP Put Options For February 20th

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available this week, for the February 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and...

Can BEAM's Gene Editing Pipeline Create Long-Term Value Amid Rivalry?

Beam Therapeutics advances base-editing pipeline with risto-cel studies and FDA designations, but no approved products and rising competition loom.

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $53.19, moving 1.45% from the previous trading session.

Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock

Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$55.30
Prev Close	$53.84
Open	$54.00
Dividend Yield	0.00%
50-Day Moving Average	$55.28
Beta	1.58
Avg. Volume	1.65M
PE Ratio	-9.91

52-Week High	$78.48
52-Week Low	$30.04
Market Capitalization	$5.28B
EPS (Annual)	-$4.34
Price to Book	2.71
Revenue Per Employee	$94,946.57
Enterprise Value/EBITDA	N/A

CRSP
CRISPR Therapeutics AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRSP News

CRSPCRISPR Therapeutics AG